Tissue kallikrein (kallidinogenase) protects against retinal ischemic damage in mice

European Journal of Pharmacology

Volumn 738, Issue , 2014, Pages 74-82

  Masuda, Tomomi ^a   Shimazawa, Masamitsu ^a   Ishizuka, Fumiya ^a   Nakamura, Shinsuke ^a   Tsuruma, Kazuhiro ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Electroretinogram; Endothelial nitric oxide synthase; Kallidinogenase; Nuclear factor kappa B; Ocular ischemic syndrome; Retinal ischemia

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALLIKREIN; OXYGEN; TISSUE KALLIKREIN;

ALPHA RHYTHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; BLOOD VESSEL PERMEABILITY; CELL COUNT; CONTROLLED STUDY; DRUG INHIBITION; ELECTRORETINOGRAPHY; ENZYME ACTIVATION; HISTOPATHOLOGY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMBRANE ELECTROPHYSIOLOGY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA; ANIMAL; CELL HYPOXIA; DRUG EFFECTS; ISCHEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHOSPHORYLATION; RETINA;

ANIMALS; CELL HYPOXIA; ENZYME ACTIVATION; ISCHEMIA; MALE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN; PERMEABILITY; PHOSPHORYLATION; REPERFUSION INJURY; RETINA; RETINAL GANGLION CELLS; TISSUE KALLIKREINS;

EID: 84902034888     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.05.033     Document Type: Article

References (40)

1. A. Atlante, P. Calissano, A. Bobba, S. Giannattasio, E. Marra, and S. Passarella Glutamate neurotoxicity, oxidative stress and mitochondria FEBS Lett. 497 2001 1 5
2. K.D. Bhoola, C.D. Figueroa, and K. Worthy Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol. Rev. 44 1992 1 80
3. I.A. Bhutto, T. Baba, C. Merges, D.S. McLeod, and G.A. Lutty Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD) Exp. Eye Res. 90 2010 155 167 10.1016/j.exer.2009.10.004
4. C. Bucolo, and F. Drago Carbon monoxide and the eye: implications for glaucoma therapy Pharmacol. Ther. 130 2011 191 201 10.1016/j.pharmthera.2011.01. 013
5. J. Chao, G. Bledsoe, H. Yin, and L. Chao The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction Biol. Chem. 387 2006 665 675 10.1515/bc.2006.085
6. I. Charles, A. Khalyfa, D.M. Kumar, R.R. Krishnamoorthy, R.S. Roque, N. Cooper, and N. Agarwal Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways Investig. Ophthalmol. Vis. Sci. 46 2005 1330 1338 10.1167/iovs.04-0363
7. Z.B. Chen, D.Q. Huang, F.N. Niu, X. Zhang, E.G. Li, and Y. Xu Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB J. Cereb. Blood Flow Metab. 30 2010 1356 1365 10.1038/jcbfm.2010.19
8. F. Drago, and C. Bucolo Therapeutic potential of nitric oxide modulation in ocular diseases Drug News Perspect. 23 2010 430 437 10.1358/dnp.2010.23.7. 1484488
9. J. Fukuhara, K. Noda, M. Murata, S. Namba, S. Kinoshita, Z. Dong, R. Ando, A. Lennikov, A. Kanda, and S. Ishida Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor Investig. Ophthalmol. Vis. Sci. 54 2013 274 279 10.1167/iovs.12-10512
10. I.M. Grumbach, W. Chen, S.A. Mertens, and D.G. Harrison A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription J. Mol. Cell. Cardiol. 39 2005 595 603 10.1016/j.yjmcc.2005.06.012
11. H. Huang, J. Shen, and S.A. Vinores Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye PLoS One 6 2011 e21411 10.1371/journal.pone.0021411
12. S. Imai, Y. Inokuchi, S. Nakamura, K. Tsuruma, M. Shimazawa, and H. Hara Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina Eur. J. Pharmacol. 642 2010 77 85 10.1016/j.ejphar.2010.05.057
13. F. Ishizuka, M. Shimazawa, Y. Inoue, Y. Nakano, H. Ogishima, S. Nakamura, K. Tsuruma, H. Tanaka, N. Inagaki, and H. Hara Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-kappa B and spleen tyrosine kinase activation Investig. Ophthalmol. Vis. Sci. 54 2013 5807 5816 10.1167/iovs.13-11932
14. F. Ishizuka, M. Shimazawa, N. Umigai, H. Ogishima, S. Nakamura, K. Tsuruma, and H. Hara Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice Eur. J. Pharmacol. 703 2013 1 10 10.1016/j.ejphar.2013. 02.007
15. M. Janaky, A. Grosz, E. Toth, K. Benedek, and G. Benedek Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG Doc. Ophthalmol. 114 2007 45 51 10.1007/s10633-006-9038-5
16. N. Jo, G.S. Wu, and N.A. Rao Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury Investig. Ophthalmol. Vis. Sci. 44 2003 4054 4060
17. N. Kato, Y. Hou, Z. Lu, C. Lu, H. Nagano, K. Suzuma, H. Takagi, and Y. Matsumoto Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: potential roles of vascular endothelial growth factor and nitric oxide Eur. J. Pharmacol. 606 2009 187 190 10.1016/j.ejphar.2009.01.027
18. A.C. Koong, E.Y. Chen, and A.J. Giaccia Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues Cancer Res. 54 1994 1425 1430
19. C. Kupatt, R. Hinkel, R. Vachenauer, J. Horstkotte, P. Raake, T. Sandner, R. Kreuzpointner, F. Muller, S. Dimmeler, O. Feron, and P. Boekstegers VEGF165 transfection decreases postischemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation FASEB J. 17 2003 705 707 10.1096/fj.02-0673fje
20. L. Lu, J.Q. Zhang, F.J. Ramires, and Y. Sun Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue Biochem. Biophys. Res. Commun. 320 2004 907 913 10.1016/j.bbrc.2004.06.034
21. H. Nagano, P.Z. Wei, C.Q. Wen, T. Jomori, H. Oku, T. Ikeda, Y. Saito, and Y. Tano Effects of kallidinogenase on ischemic changes induced by repeated intravitreal injections of endothelin-1 in rabbit retina Curr. Eye Res. 32 2007 113 122 10.1080/02713680601160602
22. S. Nakamura, S. Imai, H. Ogishima, K. Tsuruma, M. Shimazawa, and H. Hara Morphological and functional changes in the retina after chronic oxygen-induced retinopathy PLoS One 7 2012 e32167 10.1371/journal.pone.0032167
23. S. Nakamura, N. Morimoto, K. Tsuruma, H. Izuta, Y. Yasuda, N. Kato, T. Ikeda, M. Shimazawa, and H. Hara Tissue kallikrein inhibits retinal neovascularization via the cleavage of vascular endothelial growth factor-165 Arterioscler. Thromb. Vasc. Biol. 31 2011 1041 1048 10.1161/atvbaha.111.223594
24. Y. Nonaka, A. Koumura, K. Hyakkoku, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone J. Pharmacol. Exp. Ther. 330 2009 13 22 10.1124/jpet.109.151548
25. H. Ogishima, S. Nakamura, T. Nakanishi, S. Imai, M. Kakino, F. Ishizuka, K. Tsuruma, M. Shimazawa, and H. Hara Ligation of the pterygopalatine and external carotid arteries induces ischemic damage in the murine retina Investig. Ophthalmol. Vis. Sci. 52 2011 9710 9720 10.1167/iovs.11-8160
26. K. Osuka, Y. Watanabe, N. Usuda, A. Nakazawa, M. Tokuda, and J. Yoshida Modification of endothelial NO synthase through protein phosphorylation after forebrain cerebral ischemia/reperfusion Stroke 35 2004 2582 2586 10.1161/01.str.0000143454.14159.28
27. W. Qin, W. Lu, H. Li, X. Yuan, B. Li, Q. Zhang, and R. Xiu Melatonin inhibits IL1beta-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-kappaB activation J. Endocrinol. 214 2012 145 153
28. D. Regoli, and J. Barabe Pharmacology of bradykinin and related kinins Pharmacol. Rev. 32 1980 1 46 10.1530/joe-12-0147
29. D. Regoli, S. Nsa Allogho, A. Rizzi, and F.J. Gobeil Bradykinin receptors and their antagonists Eur. J. Pharmacol. 348 1998 1 10
30. C. Ristori, L. Filippi, M. Dal Monte, D. Martini, M. Cammalleri, P. Fortunato, G. la Marca, P. Fiorini, and P. Bagnoli Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade Investig. Ophthalmol. Vis. Sci. 52 2011 155 170 10.1167/iovs.10-5536
31. T. Sato, H. Oku, K. Tsuruma, K. Katsumura, M. Shimazawa, H. Hara, T. Sugiyama, and T. Ikeda Effect of hypoxia on susceptibility of RGC-5 cells to nitric oxide Investig. Ophthalmol. Vis. Sci. 51 2010 2575 2586 10.1167/iovs.09-4303
32. A. Sivalingam, G.C. Brown, and L.E. Magargal The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment Int. Ophthalmol. 15 1991 15 20
33. D. Stanimirovic, and K. Satoh Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation Brain Pathol. 10 2000 113 126
34. G. Tezel, and X. Yang Caspase-independent component of retinal ganglion cell death, in vitro Investig. Ophthalmol. Vis. Sci. 45 2004 4049 4059 10.1167/iovs.04-0490
35. K. Tsuruma, Y. Tanaka, M. Shimazawa, and H. Hara Induction of amyloid precursor protein by the neurotoxic peptide, amyloid-beta 25-35, causes retinal ganglion cell death J. Neurochem. 113 2010 1545 1554 10.1111/j.1471-4159.2010. 06724.x
36. C.F. Xia, H. Yin, C.V. Borlongan, L. Chao, and J. Chao Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis Hypertension 43 2004 452 459 10.1161/01.HYP.0000110905. 29389.e5
37. C.F. Xia, H. Yin, Y.Y. Yao, C.V. Borlongan, L. Chao, and J. Chao Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis Hum. Gene Ther. 17 2006 206 219 10.1089/hum.17.206 (2006)
38. T. Yamaguchi, H. Nagano, M. Yamaguchi, T. Suzuki, Y. Saito, and Y. Tano The effects of kallidinogenase on choroidal blood flow in a hypertensive rabbit model Curr. Eye Res. 18 1999 417 422
39. T. Yang, K.E. Roder, and T.J. Abbruscato Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions J. Pharm. Sci. 96 2007 3196 3213 10.1002/jps.21002
40. H. Yin, L. Chao, and J. Chao Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion Life Sci. 82 2008 156 165 10.1016/j.lfs.2007.10. 021